Eli Lilly (LLY) Sale and Maturity of Investments (2009 - 2025)
Eli Lilly (LLY) reported Sale and Maturity of Investments - Total of $132 million for Q4 2025, up 135.7% from $56 million a year earlier but down 76.3% from the prior quarter.
Eli Lilly (LLY) Sale and Maturity of Investments (2009 - 2025) Analysis & Trends
For FY2025, Eli Lilly posted Sale and Maturity of Investments - Total of $964 million, up 157.8% from FY2024.
- Sale and Maturity of Investments - Total has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
- By year, Sale and Maturity of Investments - Total came in at $374 million in FY2024 (-26.4%), $508 million in FY2023 (+9.6%), $463.6 million in FY2022 (-45.3%) and $847.4 million in FY2021 (-4.4%).
- Five-year quarterly Sale and Maturity of Investments - Total spans a low of -$123.4 million in Q4 2023 and a high of $556.1 million in Q3 2025.
- Year over year, Sale and Maturity of Investments - Total has now increased in each of the last four quarters, with growth averaging 108.2% over the last seven quarters.
- The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q3 2025 (growth of 719.0%); the low point was Q1 2024 (a decline of 79.5%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $556.1 million (Q3 2025), $204.3 million (Q2 2025) and $71.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 132.00 Mn |
| Sep 30, 2025 | 556.10 Mn |
| Jun 30, 2025 | 204.30 Mn |
| Mar 31, 2025 | 71.60 Mn |
| Dec 31, 2024 | 56.00 Mn |
| Sep 30, 2024 | 67.90 Mn |
| Jun 30, 2024 | 179.60 Mn |
| Mar 31, 2024 | 70.50 Mn |
| Dec 31, 2023 | -123.40 Mn |
| Sep 30, 2023 | 133.40 Mn |
| Jun 30, 2023 | 154.60 Mn |
| Mar 31, 2023 | 343.40 Mn |
| Dec 31, 2022 | 128.90 Mn |
| Sep 30, 2022 | 108.60 Mn |
| Jun 30, 2022 | 118.00 Mn |
| Mar 31, 2022 | 108.10 Mn |
| Dec 31, 2021 | 263.60 Mn |
| Sep 30, 2021 | 100.60 Mn |
| Jun 30, 2021 | 194.40 Mn |
| Mar 31, 2021 | 288.80 Mn |
Eli Lilly Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();